TAAR1 and schizophrenia: In addition, activation of peripheral TAAR1 receptors decreases appetite and increases satiety, delays gastric emptying, reduces fasting glucose in the liver, and modulates insulin production, raising the possibility that TAAR1 agonists may reduce the cardiometabolic burden associated with schizophrenia and antipsychotic treatment (Espinoza et al., 2011; Correll et al., 2022a).